Lilly Collaborates with DexCom to Utilize Dexcom CGM in its Personalized Diabetes Management System

Lilly Collaborates with DexCom to Utilize Dexcom CGM in its Personalized Diabetes Management System

Shots:

  • Lilly enters into a non-exclusive commercialization agreement with DexCom to integrate Dexcom’s CGM device in both the pen- and pump-based platforms, designed to improve diabetes management
  • The collaboration will integrate connected insulin delivery devices, software and analysis to aid patients with T1D and T2D and provide personalized information to HCPs to simplify diabetes management
  • The pen-based platform is to integrate personalized data from a prefilled, disposable insulin pen with data from glucose-sensing technologies into an app while the pump-based platform is used to integrate insulin pump, CGM and a handheld controller or an app controlling the system to automate insulin dosing

Click here to­ read full press release/ article | Ref: Eli Lilly | Image: cbs4indy